Staphylococcus epidermidis endocarditis: a community-acquired methicillin-resistant isolate.
We have described a patient with community-acquired, methicillin-resistant Staphylococcus epidermidis endocarditis that occurred on a prolapsing mitral valve. The patient was successfully treated with vancomycin and rifampin for six weeks and had no signs of relapse four months later.
D003428:Cross Infection; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000209:etiology*; D006801:Humans; D008297:Male; D008712:Methicillin / Q000494:pharmacology*; D008875:Middle Aged; D008943:Mitral Valve / Q000382:microbiology; D010403:Penicillin Resistance; D012294:Rifamycins / Q000008:administration & dosage; D013203:Staphylococcal Infections / Q000209:etiology*; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification; D014640:Vancomycin / Q000008:administration & dosage
D012294:Rifamycins; D014640:Vancomycin; D008712:Methicillin